The European Medicines Agency (EMA) has given the green light for the first Alzheimer's therapy in the EU that targets the ...

Impaired mitophagy has been strongly associated with neurodegenerative disorders like Alzheimer's and Parkinson's disease, ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

The AD risk factors/hits include high exposure to traffic-related air pollution (TRAP) and infections, as well as factors ...

From overcoming fear to cherishing small moments, Alzheimer's caregivers share transformative wisdom gained from their experiences.

Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...